What does EIT Health's Digital Health Investment Portfolio tell us?

EIT Health , founded in 2015, has emerged as a pivotal player in the European Digital Health landscape. With a mission to accelerate entrepreneurship and innovation in health, EIT Health aims to improve the sustainability of healthcare systems, promote healthy living, and enhance the overall well-being of European citizens.

We deliberately excluded public funding entities from our recent analysis of impactful investors in early-stage #DigitalHealth ventures. Consequently, EIT Health was not featured in our primary review. However, their significant contribution warrants closer scrutiny, particularly given their instrumental role in scaling Digital Health innovations across Europe.

Since its establishment, EIT Health has demonstrated a strong commitment to fostering digital health innovation, making a remarkable 76 investments. Our review, which focused on ventures founded after 2002 and classified as Digital Health according to the Galen Growth | Insights You Can Trust Digital Health taxonomy, reveals an impressive portfolio managed by EIT Health.

EIT Health’s Digital Health portfolio includes 64 active and private ventures, which collectively have attracted $220 million in funding, though not exclusively from EIT Health. The lion's share of these ventures is European-founded, highlighting EIT Health's strategic focus on bolstering homegrown innovation.

The portfolio's average Alpha Score, a data-driven measure of venture maturity, stands at 51.8. This indicates a robust pipeline of companies progressing through various stages of development. EIT Health’s investments predominantly target three key areas: Patient Solutions, Medical Diagnostics, and Health Management Solutions.

Download the executive briefing here: https://app.hubspot.com/api/filemanager/api/v2/files/168266485837/signed-url-redirect?portalId=3944817

Among the portfolio, the top five investees, ranked by Alpha Score, include:

1. GLEAMER (France) - Specializing in AI-driven medical imaging solutions, the company is at the forefront of enhancing diagnostic accuracy and efficiency.
2. Idoven (Spain) - This venture is revolutionizing cardiac diagnostics with AI-powered solutions for early detection and prevention of cardiovascular diseases.
3. HalioDx (France) - A leader in immuno-oncology diagnostics, HalioDx provides critical insights into cancer prognosis and treatment efficacy. Acquired in 2021 by Veracyte, Inc.
4. Ochre Bio (UK) - Focused on developing RNA therapies for chronic liver diseases, Ochre Bio is pushing the boundaries of therapeutic innovation.
5. Amelia Virtual Care (Spain) - Pioneering virtual reality in mental health therapy, XRHealth offers immersive treatment options for various psychological conditions. In 2023, XRHealth (formerly Amelia) merged with Amelia Virtual Care.

The full spectrum of EIT Health’s Digital Health investees can be explored on HealthTech Alpha, providing a comprehensive overview of the ventures shaping healthcare's future.

EIT Health’s strategic investments and their substantial impact on the Digital Health sector underscore the importance of public funding bodies in fostering innovation in Europe.

#ht24